Episode 2: Evolution of ABO Incompatible Heart Transplant

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/69/98/7b/69987b7e-920b-fd8e-9cfb-16b7c7b76353/mza_12110993525845972503.jpg/600x600bb.jpg

In The Flow: Conversations with Pioneers in Pediatric Heart Failure

Neha Bansal

4 episodes

3 days ago

This podcast aims to capture the stories of trailblazers and pioneers in the field pediatric heart failure and transplantation. These leaders represent a unique tribe and I will attempt to document their contributions in maturing this field from nothingness to the incredible successes today. We should never forget where we came from and the backstory is in the struggles and even failures. A historical analysis of ideas and events uniformly brings modesty, widening of horizons and a sense of wonderment. That is the aim of this podcast. To get in touch, email me at intheflow.peds@gmail.com

Life Sciences

Science

RSS

All content for In The Flow: Conversations with Pioneers in Pediatric Heart Failure is the property of Neha Bansal and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/8717601/8717601-1607208997620-3a283cee094cc.jpg

Episode 2: Evolution of ABO Incompatible Heart Transplant

In The Flow: Conversations with Pioneers in Pediatric Heart Failure

38 minutes 40 seconds

4 years ago

Episode 2: Evolution of ABO Incompatible Heart Transplant

Dr. Lori West is Professor in the Depts. of Pediatrics, Surgery, Medical Microbiology/Immunology and Laboratory Medicine/Pathology at the University of Alberta and a pioneer in the field of ABO incompatible heart transplantation in infants. In 2001 West reported the first ever series of 10 infants who received ABO-incompatible heart transplantation (ABOi HTx) in the Hospital for Sick Children in Toronto, Canada.

Dr. Simon Urschel is an Associate Professor in the Department of Pediatrics at University of Alberta and the Clinical Director of the Pediatric Cardiac Transplant Program at Stollery Children’s Hospital. He has led the recent clinical efforts to focus on exploring the limits and boundaries and long term outcomes in these patients from large patient registries.

Transplantation of hearts from ABO-incompatible donors is contraindicated because of the risk of hyperacute rejection mediated by preformed antibodies in the recipient to blood-group antigens of the donor. Let’s listen to our two experts as to why this contraindication may not apply to newborn infants and how this field of ABOi heart transplantation has evolved.

Please check the ISHLT History Project : https://ishlt.org/about-ishlt/history-archives